From: Recent updates on CAR T clinical trials for multiple myeloma
NCT number (reference) | Target | Phase | Dosage | Number of patients | Responses |
---|---|---|---|---|---|
NCT02135406 (32) | CD19 | 1 | 1.1–6.0 × 108 CAR+T cells | 10 | VGPR: 6; PR: 2; PD: 2 |
NCT01886976 (34) | CD138 | 1/2 | 0.44–1.51 × 107 CAR+ T cells/kg | 5 | SD: 4; PD: 1 |
NCT00881920 (35) | κ light chain | 1 | 0.2–2.0 × 108 CAR+ T cells/m2 | 16 (7 MM) | 4 SD of 7 MM |